Cytiva Fibro PrismA antibody purification technology

Monday, 12 October, 2020 | Supplied by: Cytiva



Cytiva’s Fibro PrismA antibody purification technology has been designed to support the industry’s drive for increased speed and flexibility, in order to advance the development of novel therapeutics. The first product based on the company’s protein A fibre chromatography technology, it is being used to accelerate research for customers and collaborators.

Fibro chromatography technology enables rapid cycling antibody purification. In research and process development, this means Fibro PrismA can support up to 20 times increased throughput compared with traditional resins, the company claims. In clinical and commercial manufacturing, the technology will enable efficient single-use operations, by using the full unit lifetime in a single batch.

Fibro PrismA enables ultrafast purification in research and process development, allowing researchers to accelerate the drug discovery process. Clinical-scale products are set to follow.

Online: www.cytivalifesciences.com/en/au
Phone: 1800 150 522
Related Products

Thermo Scientific Tundra Cryo-TEM

The Thermo Scientific Tundra Cryo-TEM uses artificial intelligence (AI), guided automation and...

Cell Biosciences service laboratory for microbial air samplers

Cell Biosciences is now able to service ORUM Microbial Air Samplers and ORUM Compressed Gas...

Cell Guidance Systems Exo-spin 96 exosome purification kit

Cell Guidance Systems has released the Exo-spin 96 for the purification of exosomes from blood...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd